Semaglutide lowers risk of kidney failure and cardiovascular death in patients with type 2 diabetes and CKD, study results show
Experts say this is an “important trial in patients with type 2 diabetes mellitus”, offering the possibility of semiglutide as an additional treatment option for slowing the progression of chronic kidney disease.…